Insider Transactions in Q1 2025 at Exelixis, Inc. (EXEL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2025
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
8,768
-2.4%
|
$324,416
$37.8 P/Share
|
|
Feb 28
2025
|
Jack L Wyszomierski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,874
+4.16%
|
$317,480
$20.5 P/Share
|
|
Feb 28
2025
|
Julie Smith Director |
SELL
Open market or private sale
|
Direct |
19,294
-64.16%
|
$713,878
$37.62 P/Share
|
|
Feb 28
2025
|
Julie Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,294
+39.08%
|
$366,586
$19.77 P/Share
|
|
Feb 27
2025
|
Julie Smith Director |
SELL
Open market or private sale
|
Direct |
54,514
-83.49%
|
$2,071,532
$38.13 P/Share
|
|
Feb 27
2025
|
Julie Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
54,514
+34.48%
|
$1,090,280
$20.14 P/Share
|
|
Feb 26
2025
|
Amy C. Peterson EVP Prod Dev & Med Aff & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
52,192
+13.07%
|
-
|
|
Feb 26
2025
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
52,192
+8.03%
|
-
|
|
Feb 26
2025
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
47,718
+11.97%
|
-
|
|
Feb 26
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
49,209
+8.06%
|
-
|
|
Feb 26
2025
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
184,909
+15.18%
|
-
|
|
Feb 26
2025
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
59,648
+6.64%
|
-
|
|
Feb 25
2025
|
Bob Oliver Director |
SELL
Open market or private sale
|
Direct |
18,647
-35.75%
|
$689,939
$37.25 P/Share
|
|
Feb 25
2025
|
Bob Oliver Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,147
+22.5%
|
$287,793
$19.28 P/Share
|
|
Feb 24
2025
|
Christopher J. Senner EVP and CFO |
SELL
Open market or private sale
|
Direct |
29,314
-3.62%
|
$1,055,304
$36.14 P/Share
|
|
Feb 24
2025
|
Christopher J. Senner EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,314
+3.5%
|
$527,652
$18.8 P/Share
|
|
Feb 24
2025
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
177,985
+9.16%
|
-
|
|
Feb 24
2025
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
177,985
-17.34%
|
-
|
|
Feb 24
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
26,987
-5.01%
|
$971,532
$36.75 P/Share
|
|
Feb 24
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
52,636
-14.79%
|
$1,894,896
$36.98 P/Share
|
|
Feb 15
2025
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
63,570
-5.83%
|
$2,224,950
$35.0 P/Share
|
|
Feb 15
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
28,748
-2.56%
|
$1,006,180
$35.0 P/Share
|
|
Feb 15
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
18,906
-5.04%
|
$661,710
$35.0 P/Share
|
|
Feb 15
2025
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
18,134
-3.22%
|
$634,690
$35.0 P/Share
|
|
Feb 15
2025
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,591
-2.69%
|
$755,685
$35.0 P/Share
|
|
Feb 14
2025
|
Sue Gail Eckhardt Director |
SELL
Open market or private sale
|
Direct |
11,568
-14.81%
|
$404,880
$35.03 P/Share
|
|
Feb 14
2025
|
Sue Gail Eckhardt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,712
+15.52%
|
$177,376
$23.24 P/Share
|
|
Feb 14
2025
|
Maria C Freire Director |
SELL
Open market or private sale
|
Direct |
44,114
-32.65%
|
$1,499,876
$34.94 P/Share
|
|
Feb 14
2025
|
Maria C Freire Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,114
+15.11%
|
$926,394
$21.3 P/Share
|
|
Feb 14
2025
|
George Poste Director |
SELL
Open market or private sale
|
Direct |
15,874
-8.59%
|
$539,716
$34.74 P/Share
|
|
Feb 14
2025
|
George Poste Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,874
+7.91%
|
$317,480
$20.5 P/Share
|
|
Feb 14
2025
|
Mary C Beckerle Director |
SELL
Open market or private sale
|
Direct |
12,210
-15.43%
|
$415,140
$34.89 P/Share
|
|
Feb 14
2025
|
Mary C Beckerle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,354
+16.39%
|
$192,142
$23.24 P/Share
|
|
Jan 16
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
27,563
-6.85%
|
$1,019,831
$37.27 P/Share
|
|
Jan 16
2025
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
123,750
+23.52%
|
-
|
|
Jan 16
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
22,570
-3.82%
|
$835,090
$37.27 P/Share
|
|
Jan 16
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
104,106
+14.99%
|
-
|
|
Jan 16
2025
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
26,289
-4.46%
|
$972,693
$37.27 P/Share
|
|
Jan 16
2025
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
118,780
+16.76%
|
-
|
|
Jan 16
2025
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,949
-4.29%
|
$1,330,113
$37.27 P/Share
|
|
Jan 16
2025
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
132,973
+13.71%
|
-
|
|
Jan 16
2025
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
120,244
-9.94%
|
$4,449,028
$37.27 P/Share
|
|
Jan 16
2025
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
473,226
+28.11%
|
-
|